References
Elkind MM. Repair processes in radiation biology. Radiat Res 1984; 100: 425.
Behling UH. The radioprotective effect of bacterial endotoxin. In: Nowotny A (ed.) Beneficial Effects of Endotoxins. New York: Plenum Press, 1983; p. 127.
Boggs SS, Chervenick PA, Boggs DR. The effect of postirradiation bleeding or endotoxin on proliferation and differentiation of hematopoietic stem cells. Blood 1972; 40: 375.
Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony stimulating factor. Blood 1986; 76: 257–267.
Neta R, Douches SD, Oppenheim JJ. Interleukin-1 is a radioprotector. J Immunol 1986; 136: 2483–2485.
Neta R, Douches SD, Oppenheim JJ. Radioprotection by interleukin-1. In: Goldstein F, Bach JF, Wigzal H (eds) Immunoregulation by Characterized Polypeptides. UCLA Symposia on Molecular and Cellular Biology 1986; 41: 429–441.
Neta R, Oppenheim JJ, Douches SD. Interdependence of the radioprotective effects of human recombinant IL-1, TNF, G-CSF, and murine recombinant G-CSF. J Immunol 1988; 140: 108–111.
Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6: 51–95.
Durum SK, Oppenheim JJ, Neta R. Immunophysiological role of interleukin 1. In: Oppenheim JJ, Shevach E (eds) Immunophysiology: Role of Cells and Cytokines in Immunity and Inflammation. New York: Oxford University Press, in press.
Walden TL Jr, Patchen ML, Snyder SL. 16,16-Dimethylprostaglandin E increases survival in mice following irradiation. Radiat Res 1987; 109: 540–549.
Neta R, Oppenheim JJ, Douches SD, Giclas PC, Imbra RJ, Karin M. Radioprotection with IL-1. Comparison with other cytokines. In: Cinader B, Miller RG (eds) Progress of Immunology, VI. New York: Academic Press, 1986; pp. 900–909.
Neta R, Sztein MB, Oppenheim JJ, Gillis S, Douches SD.In vivo effects of IL-1. 1. Bone marrow cells are induced to cycle following administration of IL-1. J Immunol 1987; 139: 1861–1866.
Denekamp J. Cell kinetics and radiation biology. Int J Radiat Biol 1986; 49: 357.
Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin-1 (IL-1) and purified human IL-1. J Exp Med 1985; 162: 930–942.
Sipe JD, Vogel SN, Douches SD, Neta R. Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid a synthesis than interleukin-1. Lymphokine Res 1987; 93–101.
Mortensen RF, Shapiro J, Lin B-F, Douches SD, Neta R. Interaction of recombinant Interleukin-l (IL-1) and recombinant tumor necrosis factor (TNF) in the induction of mouse acute phase proteins. J Immunol 1988; 140: 2260–66.
Karin M. Metallothioeins: proteins in search of function. Cell 1985; 41: 9–11.
Goldstein IM, Charo IF. Ceruloplasmin: an acute phase reactant and antioxidant. In: Pick E (ed.) Lymphokines, 8. New York: Academic Press, 1983; pp. 373–411.
Vogel SN, Douches SD, Kaufman EN, Neta R. Induction of colony stimulating factorin vivo by recombinant interleukin-I and recombinant tumor necrosis factor. J Immunol 1987; 138: 2143–48.
Neta R., Vogel SN, Oppenheim JJ, Douches SD. Cytokines in radioproteciton. Comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF and IFN. Lymphokine Res 1986; 5: 5105–5110.
Moore MAS, Warren DJ. Synergy of interleukin-I and granulocyte colony-stimulating factor:In vivo stimulation of stem cell recovery and hematopoietic regeneration following 5-fluorouracil treatment of mice. Proc Natl Acad Sci USA 1987; 84: 7134–38.
Sieff CA. Hematopoietic growth factors. J Clin Invest 1987; 79: 1549–57.
Groopman JE. Hematopoietic growth factors: from methyl cellulose to man. Cell 1987; 50: 5–6.
Cohen AM, Zsebo KM, Inoue H, Hines D, Boone TC, Chazin VR, Tsai L, Ritch T, Souza LM.In vivo stimulation of granulopoiesis by recombinant human granulocyte colony stimulating factor. Proc Natl Acad Sci USA 1987; 84: 2484–88.
Shimanura M, Kobayashi Y, Yno A, Urabe A, Okabe T, Komatsu Y, Itoh S, Takaku F. Effect of human recombinant granulocyte colony stimulating factor on hematopoietic injury in mice induced by r-fluorouracil. Blood 1987; 69: 353–55.
Nienhuis AW, Donahue RE, Karlsson S, Clark SC, Agricola B, Antinoff N, Pierce JE, Turner P, Anderson WF, Nathan DG. Recombinant human GM-CSF shortens the period of neutropenia after autologous bone marrow transplantation in a primate model. J Clin Invest 1987; 80: 573–77.
Monroy RL, Skelly RR, MacVittie TJ, Davis TA, Sauber JJ, Clark SC, Donahue RE. The effect of recombinant GM-CSF on the recovery of the monkeys transplanted with autologous bone marrow. Blood 1987; 70: 1996–99.
Neta R, Oppenheim JJ. Cytokines in therapy of radiation injury. Blood 1988; 72: 1093–95.
Bond VP, Fliedner TM, Archambeau JO. Mammalian Radiation Lethality. A Disturbance in Cellular Kinetics. New York: Academic Press, 1965.
Nakamura S, Nakata K, Kashimoti S, Yoshida H, Yamada M. Antitumor effect of recombinant human interleukin-1 alpha against murine syngeneic tumors. Jpn J Canc Res 1986; 77: 767.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neta, R. Cytokines in radioprotection and therapy of radiation injury. Biotherapy 1, 41–45 (1989). https://doi.org/10.1007/BF02170134
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02170134